Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Multicenter Clinical Study to Evaluate The Safety and Efficiency of Human Umbilical Cord Mesenchymal Stem Cell Transfusion in Patients With Decompensated Liver Cirrhosis.

NCT03529136 is registered in ClinicalTrials.gov with Shandong Qilu Stem Cells Engineering Co., Ltd. as lead sponsor.

NCT NCT03529136
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03529136 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Multicenter Clinical Study to Evaluate The Safety and Efficiency of Human Umbilical Cord Mesenchymal Stem Cell Transfusion in Patients With Decompensated Liver Cirrhosis.
Lead sponsor
Shandong Qilu Stem Cells Engineering Co., Ltd.
Phase
Phase 2
Overall status
Unknown status
Start date
June 1, 2018
Completion date
April 30, 2020
Enrollment
252 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

decompensated liver cirrhosis